1. West Midlands Regional Genetics Laboratory, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, United Kingdom;
2. Institute of Cancer and Genomic Studies, University of Birmingham, Birmingham, United Kingdom; and
3. Diagnostic Genomic Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar